Clinical Trial Update: A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing Shared Solutions Plus MS Center Support with Shared Solutions alone in Multiple Sclerosis patients; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Glatiramer acetate (Copaxone) (glatiramer acetate)

Snippet

Sponsor: Teva Neuroscience, Inc. | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED